NextCure, Inc. (NXTC) and LCB to Unveil Promising Preclinical Data on B7-H4 ADC at AACR 2024
NextCure, Inc. (NASDAQ:NXTC) and LigaChem Biosciences, Inc.
Nextcure Inc. (NXTC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 41,744.583,333,333 | $230,430 | +5% | 0% |
| 2. | Sio Capital Michael Castor | 10,941.666,666,667 | $60,398 | +2% | 0.02% |
| 3. | ADAR1 Capital Management Daniel Schneeberger | 9,834.3,333,333,333 | $54,286 | -2% | 0.01% |
| 4. | Armistice Capital Steven Boyd | 8,666.6,666,666,667 | $47,840 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 4,903.75 | $27,069 | -36% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.75 | 150,000 | $5,512,500.00 | 2,671,856 | 2019-11-15 | Filing | |
| $15.00 | 400,000 | $6,000,000.00 | 2,521,856 | 2019-05-13 | Filing | |
| $15.00 | 50,000 | $750,000.00 | 2,254,442 | 2019-05-13 | Filing | |
| $15.00 | 350,000 | $5,250,000.00 | 2,711,013 | 2019-05-13 | Filing | |
| $15.00 | 125,000 | $1,875,000.00 | 1,103,570 | 2019-05-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 222,654.66,666,667 | $1,229,054 | 0.08% | |
| 2. | 191,883.16,666,667 | $1,059,195 | 0.14% | |
| 3. | 13,137.166,666,667 | $870,206 | 0.15% | |
| 4. | 85,455.75 | $471,716 | 0% | |
| 5. | 72,668.333,333,333 | $401,129 | 0% |
News See All
Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
Is NXTC A Good Stock To Buy Now?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
NextCure, Inc. (NXTC): Are Hedge Funds Right About This Stock?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On NextCure, Inc. (NXTC)
We hate to say this but, we told you so.
Is NextCure, Inc. (NXTC) A Good Stock To Buy ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Funds Welcomed NextCure, Inc. (NXTC) With Open Arms
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock.
Billionaire Hedge Funds
